Narrative review / 2009
Excess iron presents a risk for cancer, and controlling body iron stores may offer a strategy for cancer prevention.
This review discusses iron's role in carcinogenesis, noting that iron acts as a double-edged sword whose excess is a cancer risk, likely via reactive oxygen species generation. Pathological conditions like hemochromatosis, chronic hepatitis B and C, asbestos exposure, and endometriosis are recognized iron overload-related cancer risks in humans, and iron is carcinogenic in animal experiments. The authors also highlight an epidemiological study showing iron reduction through phlebotomy lowered cancer risk in an apparently normal population. They propose that careful regulation of body iron stores may serve as a cancer prevention strategy.
- Study type
- Narrative review
- Who was studied
- Human and animal data on iron overload and cancer
- What was measured
- Carcinogenesis and cancer risk related to iron overload
THE PAPER
Role of iron in carcinogenesis: cancer as a ferrotoxic disease.
Toyokuni S. Cancer Sci, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.